Stock Research: ST Pharm

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

ST Pharm

KOSDAQ:A237690 KR7237690003
58
  • Value
    12
  • Growth
    90
  • Safety
    Safety
    14
  • Combined
    20
  • Sentiment
    94
  • 360° View
    360° View
    58
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

STPharm Co.,Ltd. is a Korea-based company primarily engaged in the manufacture of pharmaceutical products, including generic active pharmaceutical ingredients (APIs) like tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, and voriconazole, as well as new medicine APIs. The company operates in the pharmaceutical industry and distributes its products within the domestic market and to overseas markets. In the last fiscal year, the company had a market cap of $1278 million, profits of $65 million, and revenue of $185 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
12 14 12 9
Growth
90 96 51 99
Safety
Safety
14 20 20 8
Sentiment
94 52 39 98
360° View
360° View
58 55 10 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
91 76 82 93
Opinions Change
50 28 67 83
Pro Holdings
n/a 22 4 51
Market Pulse
97 80 41 72
Sentiment
94 52 39 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
12 14 12 9
Growth
90 96 51 99
Safety Safety
14 20 20 8
Combined
20 30 6 28
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
12 19 19 5
Price vs. Earnings (P/E)
12 13 17 7
Price vs. Book (P/B)
12 17 20 7
Dividend Yield
28 30 33 23
Value
12 14 12 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
93 96 67 91
Profit Growth
67 82 73 93
Capital Growth
23 52 48 21
Stock Returns
92 84 15 99
Growth
90 96 51 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
37 26 29 28
Refinancing
22 33 37 15
Liquidity
22 90 24 4
Safety Safety
14 20 20 8

Similar Stocks

Discover high‑ranked alternatives to ST Pharm and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

KT

KOSE:A030200
Country: South Korea
Industry: Integrated Telecommunication
Size: Large
Full Stock Analysis

NH Investment & Securities

KOSE:A005940
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Medium
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: